Documentos de Kay G.A. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Área de conocimiento: "Inmunología"

Subtipo de publicación

Publisher

Scientific Reports(2)

Emerging Infectious Diseases(1)

Journal of Infection(1)

Área temáticas

Microorganismos, hongos y algas(4)

Enfermedades(3)

Genética y evolución(1)

Historia natural de los organismos(1)

Medicina y salud(1)

Área de conocimiento

Microbiología(1)

Objetivos de Desarrollo Sostenible

ODS 17: Alianzas para lograr los objetivos(4)

ODS 3: Salud y bienestar(4)

ODS 9: Industria, innovación e infraestructura(3)

ODS 10: Reducción de las desigualdades(1)

Año de Publicación

Origen

Palabras Claves

Lateral flow immunoassays(1)

Igg seroconversion and pathophysiology in severe acute respiratory syndrome coronavirus 2 infection

Abstract: We investigated the dynamics of seroconversion in severe acute respiratory syndrome coronavirus 2 (S

Palabras claves:

Adams E.R., Augustin Y., Byrne R.L., Clark D.J., Cocozza M., Cubas-Atienzar A.I., Cuevas L.E., Cusinato M., Davies B.M.O., Davis M., Davis P., Duvoix A., Eckersley N.M., Fitchett J.R.A., Forton D., Fraser A.J., Garrod G., Hadcocks L., Hu Q., Johnson M., Kay G.A., Kirwan D.E., Klekotko K., Krishna S., Lewis Z., Macallan D.C., Mensah-Kane J., Monahan I., Moore C.M., Nebe-Von-Caron G., Owen S.I., Planche T., Sainter C., Sall A.A., Schouten J., Staines H.M., Stefanie K. Menzies, Wilkins J., Williams C.T., Woolston K.

Self-sampling of capillary blood for SARS-CoV-2 serology

Abstract: Serological testing is emerging as a powerful tool to progress our understanding of COVID-19 exposur

Palabras claves:

Adams E.R., Brown L., Byrne R.L., Cubas-Atienzar A.I., Cuevas L.E., Fitchett J.R.A., Fletcher T.E., Fraser A.J., Garrod G., Kay G.A., Kontogianni K., Krishna S., Owen S.I., Planche T., Sainter C., Staines H.M., Stefanie K. Menzies, Turtle L., Williams C.T.

SARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests

Abstract: Severe acute respiratory coronavirus 2 (SARS-CoV-2) has spread globally since its emergence in 2019.

Palabras claves:

Adams E.R., Clark D.J., Cuevas L.E., Davies B.M.O., Eckersley N.M., Giorgi E., Hughes G.L., Kay G.A., Kirwan D.E., Krishna S., Owen S.I., Patterson E.I., Planche T., Staines H.M., Stefanie K. Menzies, Williams C.T.

Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies

Abstract: Background: There are an abundance of commercially available lateral flow assays (LFAs) that detect

Palabras claves:

covid-19, IGG, Igm, Lateral flow immunoassays, SARS-COV-2

Adams E.R., Baldwin L., Brown L., Byrne R.L., Collins A.M., Cubas-Atienzar A.I., Cuevas L.E., de Vos M., Edwards T., Escadafal C., Ferreira D.M., Fletcher T.E., Fraser A.J., Garrod G., Hyder-Wright A., Kay G.A., Kontogianni K., Mason J., Mitsi E., Owen S.I., Planche T., Sacks J.A., Stefanie K. Menzies, Taylor J., Todd S., Tully C., Williams C.T.